Scotia Capital Inc. Moderna, Inc. Transaction History

Scotia Capital Inc.

$17.8 Billion
Q3 2024

A detailed history of Scotia Capital Inc. transactions in Moderna, Inc. stock. As of the latest transaction made, Scotia Capital Inc. holds 19,576 shares of MRNA stock, worth $721,375. This represents 0.01% of its overall portfolio holdings.

Number of Shares

19,576

Previous 13,176 48.57%

Holding current value

$721,375

Previous $1.56 Million 16.37%

% of portfolio

0.01%

Previous 0.01%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$63.64 - $125.14 $407,296 - $800,896	6,400 Added 48.57%	19,576 $1.31 Million
Q2 2024 Aug 14, 2024	SELL	$101.21 - $166.61 $46,354 - $76,307	-458 Reduced 3.36%	13,176 $1.56 Million
Q1 2024 May 14, 2024	BUY	$85.37 - $115.44 $73,930 - $99,971	866 Added 6.78%	13,634 $1.45 Million
Q4 2023 Feb 12, 2024	SELL	$69.51 - $104.43 $53,453 - $80,306	-769 Reduced 5.68%	12,768 $1.27 Million
Q3 2023 Nov 14, 2023	BUY	$96.41 - $126.61 $529,194 - $694,962	5,489 Added 68.2%	13,537 $1.4 Million
Q2 2023 Aug 03, 2023	SELL	$118.5 - $160.53 $1.13 Million - $1.54 Million	-9,569 Reduced 54.32%	8,048 $977,000
Q1 2023 May 11, 2023	SELL	$135.66 - $197.02 $109,613 - $159,192	-808 Reduced 4.39%	17,617 $2.71 Million
Q4 2022 Feb 09, 2023	SELL	$118.38 - $210.04 $327,320 - $580,760	-2,765 Reduced 13.05%	18,425 $3.31 Million
Q3 2022 Nov 10, 2022	BUY	$118.07 - $194.18 $6,611 - $10,874	56 Added 0.26%	21,190 $2.51 Million
Q2 2022 Aug 05, 2022	SELL	$117.13 - $176.59 $60,790 - $91,650	-519 Reduced 2.4%	21,134 $3.02 Million
Q1 2022 May 09, 2022	BUY	$126.46 - $235.05 $1.69 Million - $3.15 Million	13,395 Added 162.21%	21,653 $3.73 Million
Q4 2021 Feb 11, 2022	SELL	$225.82 - $368.51 $1.59 Million - $2.6 Million	-7,045 Reduced 46.04%	8,258 $2.1 Million
Q3 2021 Nov 12, 2021	BUY	$221.9 - $484.47 $1.02 Million - $2.23 Million	4,611 Added 43.13%	15,303 $5.89 Million
Q2 2021 Aug 12, 2021	BUY	$129.91 - $234.98 $705,541 - $1.28 Million	5,431 Added 103.23%	10,692 $2.51 Million
Q1 2021 May 06, 2021	BUY	$109.18 - $185.98 $256,682 - $437,238	2,351 Added 80.79%	5,261 $689,000
Q4 2020 Feb 11, 2021	SELL	$65.74 - $169.86 $181,310 - $468,473	-2,758 Reduced 48.66%	2,910 $304,000
Q3 2020 Nov 12, 2020	BUY	$54.34 - $94.85 $80,097 - $139,808	1,474 Added 35.15%	5,668 $401,000
Q2 2020 Aug 11, 2020	BUY	$29.67 - $80.0 $124,435 - $335,520	4,194 New	4,194 $269,000

Others Institutions Holding MRNA

# of Institutions

954

Shares Held

241M

Call Options Held

10.6M

Put Options Held

18.7M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Scotia Capital Inc., based on Form 13F filings with the SEC.

News

Stay updated on Scotia Capital Inc. with notifications on news.

Account

Scotia Capital Inc. Moderna, Inc. Transaction History